1 – 10 of 153
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Fluid Biomarker Changes After Amyloid-β–Targeting Drugs
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
(
- Contribution to journal › Article
-
Mark
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
(
- Contribution to journal › Article
-
Mark
Highly Accurate Blood Test for Alzheimer's Disease Comparable or Superior to Clinical CSF Tests
(
- Contribution to journal › Article
-
Mark
Plasma Biomarker Strategy for Selecting Patients with Alzheimer Disease for Antiamyloid Immunotherapies
(
- Contribution to journal › Article
-
Mark
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns
(
- Contribution to journal › Article
-
Mark
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
(
- Contribution to journal › Article
-
Mark
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
The implications of amyloid-β pathology : only time will tell
(
- Contribution to journal › Article